drugset / Trial / NCT02312908

Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism

NCT02312908

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether clonazepam is effective and safe in the treatment of rapid eye movement behavior disorder (RBD) of patients with Parkinson's disease (PD).

Timeline

Start
2015-03
Primary completion
2016-03
Completion
2016-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule 0.5 mg Oral